Aims

To support the free and open dissemination of research findings and information on alcoholism and alcohol-related problems. To encourage open access to peer-reviewed articles free for all to view.

For full versions of posted research articles readers are encouraged to email requests for "electronic reprints" (text file, PDF files, FAX copies) to the corresponding or lead author, who is highlighted in the posting.

___________________________________________

Monday, February 21, 2011

The Check Effect Reconsidered



The “check effect” refers to the use of disability payments to purchase illegal drugs or alcohol. 

This article describes subsequent research concerning three interrelated issues: the check effect, whether receipt of disability payments is associated with more overall substance use, and potential policy responses to misuse of disability payments for substances. 

Review and synthesis of published articles. 

Increased substance use at the beginning of the month has been described in a variety of settings. The tendency to purchase substances at the beginning of the month is impacted by household wealth, the tendency to discount future rewards, and cyclical economic activity. 

However, in naturalistic observational cohort studies, beneficiaries who receive disability payments had no greater substance use than those without disability payments. 

Potential policy responses to misspending of disability checks include financial counseling that discourages spending on drugs, and the assignment of a representative payee to prevent misuse of benefits for substances. 

Assignment of a representative payee per se has not been associated with reduced substance use but payeeship administered by agencies that integrate payee practice into treatment has been. 

Disability payments impact the timing of substance use, but receipt of disability payments is not associated with more overall substance use than unalleviated poverty.

Money management-based clinical interventions, which may involve assignment of a representative payee, can minimize the purchase of substances with disability payments.



Request Reprint E-Mail:  marc.rosen@yale.edu.